Envestnet Asset Management Inc Abbott Laboratories Transaction History

Envestnet Asset Management Inc

$263 Billion
Q1 2024

A detailed history of Envestnet Asset Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Envestnet Asset Management Inc holds 4,411,545 shares of ABT stock, worth $458 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

4,411,545

Previous 3,892,689 13.33%

Holding current value

$458 Million

Previous $428 Million 17.03%

% of portfolio

0.19%

Previous 0.18%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$109.52 - $120.96 $56.8 Million - $62.8 Million	518,856 Added 13.33%	4,411,545 $501 Million
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $23.9 Million - $29.3 Million	265,316 Added 7.31%	3,892,689 $428 Million
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $81.6 Million - $97.9 Million	853,997 Added 30.79%	3,627,373 $351 Million
Q2 2023 Aug 04, 2023	BUY	$100.78 - $112.29 $5.81 Million - $6.47 Million	57,650 Added 2.12%	2,773,376 $302 Million
Q1 2023 May 11, 2023	BUY	$96.86 - $114.01 $1.62 Million - $1.9 Million	16,700 Added 0.62%	2,715,726 $275 Million

Q4 2022 Feb 07, 2023	BUY	$95.06 - $111.52 $11.4 Million - $13.4 Million	120,045 Added 4.65%	2,699,026 $296 Million
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $20.7 Million - $24 Million	214,089 Added 9.05%	2,578,981 $250 Million
Q2 2022 Aug 03, 2022	SELL	$102.07 - $123.37 $22.8 Million - $27.6 Million	-223,591 Reduced 8.64%	2,364,892 $257 Million
Q1 2022 May 04, 2022	BUY	$114.02 - $139.04 $11 Million - $13.4 Million	96,710 Added 3.88%	2,588,483 $306 Million
Q4 2021 Feb 04, 2022	SELL	$115.53 - $141.46 $35.4 Million - $43.3 Million	-306,083 Reduced 10.94%	2,491,773 $351 Million
Q3 2021 Oct 07, 2021	BUY	$116.66 - $129.06 $13 Million - $14.4 Million	111,668 Added 4.16%	2,797,856 $331 Million
Q2 2021 Aug 04, 2021	SELL	$105.79 - $124.53 $15.9 Million - $18.7 Million	-150,310 Reduced 5.3%	2,686,188 $311 Million
Q1 2021 May 04, 2021	BUY	$108.84 - $128.23 $73.3 Million - $86.3 Million	673,085 Added 31.11%	2,836,498 $340 Million
Q4 2020 Feb 02, 2021	BUY	$105.0 - $114.42 $18.6 Million - $20.3 Million	177,603 Added 8.94%	2,163,413 $237 Million
Q3 2020 Oct 09, 2020	BUY	$91.64 - $111.29 $17 Million - $20.7 Million	185,698 Added 10.32%	1,985,810 $216 Million
Q2 2020 Jul 08, 2020	BUY	$76.57 - $98.0 $17.7 Million - $22.7 Million	231,793 Added 14.78%	1,800,112 $165 Million
Q1 2020 Apr 23, 2020	BUY	$62.82 - $91.86 $16.7 Million - $24.5 Million	266,557 Added 20.48%	1,568,319 $124 Million
Q4 2019 Feb 11, 2020	BUY	$78.51 - $87.4 $26.3 Million - $29.3 Million	335,173 Added 34.68%	1,301,762 $113 Million
Q3 2019 Oct 17, 2019	BUY	$81.84 - $88.74 $8.44 Million - $9.15 Million	103,163 Added 11.95%	966,589 $80.9 Million
Q2 2019 Aug 02, 2019	BUY	$72.88 - $85.0 $4.65 Million - $5.43 Million	63,864 Added 7.99%	863,426 $72.6 Million
Q1 2019 May 10, 2019	SELL	$66.22 - $80.06 $11.8 Million - $14.3 Million	-178,763 Reduced 18.27%	799,562 $63.9 Million
Q4 2018 Feb 13, 2019	BUY	$65.56 - $74.27 $62.8 Million - $71.1 Million	957,800 Added 4666.5%	978,325 $70.8 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $7.28 Million - $8.78 Million	-119,642 Reduced 85.36%	20,525 $1.51 Million
Q2 2018 Aug 10, 2018	BUY	$57.57 - $63.54 $154,287 - $170,287	2,680 Added 1.95%	140,167 $8.55 Million
Q1 2018 May 09, 2018	SELL	$56.27 - $63.62 $3.49 Million - $3.95 Million	-62,067 Reduced 31.1%	137,487 $8.21 Million
Q4 2017 Feb 20, 2018	SELL	$53.68 - $57.47 $1.3 Million - $1.39 Million	-24,198 Reduced 10.81%	199,554 $11.4 Million
Q3 2017 Nov 13, 2017	SELL	$48.06 - $53.64 $351,943 - $392,805	-7,323 Reduced 3.17%	223,752 $11.9 Million
Q2 2017 Aug 14, 2017	BUY	N/A	231,075	231,075 $11.2 Million

Others Institutions Holding ABT

# of Institutions

3,127

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $182B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Abbott Laboratories Transaction History